ARCHIVES

ACS Board allocated $37.5 Million to Research; More Coming

This article is from The Cancer Letter archive.

Vol. 13 No. 08 | February 20, 1987

Download PDF Visit The Full Archive

Related Articles

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Myriad In Partnership To Market Products.

December 14, 2001

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

Greenberg: More Work Needs to be Done

November 7, 2014